TrialAdvances in therapy2025

Pembrolizumab in Patients of Chinese Descent with Microsatellite Instability-high/Mismatch Repair Deficient Advanced Solid Tumors: KEYNOTE-158 Final Analysis.

Xiaohua Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.